The impact of non-pharmacologic interventions on respiratory syncytial virus hospitalization during the COVID-19 pandemic: A retrospective study from Saudi Arabia.
Autor: | AlBahrani S; Infectious Disease Unit, Specialty Internal Medicine, King Fahd Military Medical Complex, Dhahran, College of medicine-Imam Abdulrahaman Bin Faisal University, Dammam, Saudi Arabia., Al Otaibi TO; Pediatric Department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia., Alqahtani JS; Department of Respiratory Care, Prince Sultan Military College of Health Sciences, Dammam, Saudi Arabia., AlZahrani SJ; Molecular laboratory department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia., Sharbini DA; Immunology and serology Department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia., AlMuyidi FW; Pediatric Department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia., Alotaibi AO; Pediatric Department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia., Olayan OAA; Pediatric Department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia., AlMasoud SF; Molecular laboratory department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia., Bo Obaid MAH; Molecular laboratory department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia., Altawfiq KJA; Medical Interns, Alfaisal University, Riyadh, Saudi Arabia., Jebakumar AZ; Vice deanship of postgraduate studies and Research, Prince Sultan Military College of Health Sciences, Dhahran, Saudi Arabia., Al-Tawfiq JA; Infectious Disease Unit, Specialty Internal Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Infectious Disease Division, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Infectious Disease Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: jaffar.tawfiq@jhah.com. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of infection and public health [J Infect Public Health] 2024 Jan; Vol. 17 (1), pp. 96-101. Date of Electronic Publication: 2023 Nov 09. |
DOI: | 10.1016/j.jiph.2023.11.010 |
Abstrakt: | Background: Acute respiratory tract infections (ARTIs) are frequently observed in infants and young children. The dynamics and transmission of ARTIs have been significantly impacted by the global COVID-19 pandemic. This study investigates the change in admission rates of Respiratory Syncytial virus (RSV) in a hospital in Saudi Arabia. Methods: The study included hospitalized pediatric patients who underwent RSV testing in three periods: pre-pandemic (2019), during the pandemic (2020-2021), and the immediate post-pandemic (2022). RSV testing was conducted using either PCR or antigen tests. Results: Between January 2019 to December 2022, out of 927 tested patients, 173 (18.7%) were positive for RSV. The yearly positivity rates were as follows: 42 (35.6%) of 118, 24 (33.3%) of 72, 15 (18.5%) of 81, and 92 (14%) of 656, yearly from 2019 to 2022, respectively (P < 0.00001). Among all cases, 150 (16.2%) required hospitalization, including 94 (62.7%) males and 56 (37.3%) females. The admission rate to the intensive care unit (ICU) was 25 (16.7%), and mechanical ventilation was required for 10 (6.6%) patients. The overall case fatality rate was 0.7%. A Binary logistic regression analysis showed upper respiratory tract symptoms were more common in patients admitted in 2019 compared to 2022 (odd ratio:20.9, 95% CI: 4.2-104.1, P value < 0.0001). Conclusion: The study showed that there were differences in RSV infection before and after COVID-19. Understanding how COVID-19 mitigation measures affect RSV transmission can aid in the development of effective prevention and control strategies. Competing Interests: Declaration of Competing Interest Authors have no conflict of interest to declare. (Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |